Comparison on the short-term effects of atorvastatin or provastatin combined with clopidogrel for patients undergoing coronary stenting:a randomized controlled trial
- VernacularTitle:冠状动脉支架术后阿托伐他汀或普伐他汀与氯吡格雷联合治疗的近期疗效比较——随机对照试验
- Author:
Yaling HAN
;
Chengyang LI
;
Yi LI
- Publication Type:Journal Article
- Keywords:
angioplasty,transluminal,percutaneous coronary;
clopidogrel;
atorvastatin;
provastatin
- From:
Medical Journal of Chinese People's Liberation Army
2001;0(08):-
- CountryChina
- Language:Chinese
-
Abstract:
0.05),as well as in the composite of MACCE(2.51% vs 3.10%,P=0.523)between the two groups.Also,no significant difference existed in the rate of SAT(0.16% vs 0.16%,P=1.000)and hemorrhagic events(2.51% vs 2.12%,P=0.652)between the two groups.Kaplan-Meier survival analysis showed the cumulative hazard rate for the MACCE was similar(P=0.523).Conclusions Short-term therapeutic effects of atorvastatin 20mg/d combined with clopidogrel for the patients undergoing coronary stenting is similar to that of provastatin combined with clopidogrel.Long-term therapeutic efficiency and safety of the two strategies need to be further investigated.
